These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 23231976

  • 1. PARP inhibitors: targeting the right patients.
    Azvolinsky A.
    J Natl Cancer Inst; 2012 Dec 19; 104(24):1851-2. PubMed ID: 23231976
    [No Abstract] [Full Text] [Related]

  • 2. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.
    Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, Oza A.
    Lancet Oncol; 2011 Sep 19; 12(9):852-61. PubMed ID: 21862407
    [Abstract] [Full Text] [Related]

  • 3. An Achilles' heel for breast cancer?
    Caldecott KW, Chalmers A.
    Nat Struct Mol Biol; 2005 May 19; 12(5):387-8. PubMed ID: 15870726
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Role of oncogenetics in the treatment of breast and ovarian cancer].
    Langmár Z, Németh M.
    Orv Hetil; 2011 Jul 24; 152(30):1214-5. PubMed ID: 21733796
    [No Abstract] [Full Text] [Related]

  • 6. Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.
    Oda K, Tanikawa M, Sone K, Mori-Uchino M, Osuga Y, Fujii T.
    Int J Clin Oncol; 2017 Aug 24; 22(4):611-618. PubMed ID: 28508305
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.
    Stebbing J, Ellis P, Tutt A.
    Future Oncol; 2010 Apr 24; 6(4):485-6. PubMed ID: 20373860
    [No Abstract] [Full Text] [Related]

  • 9. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
    Schreiber V, Illuzzi G, Héberlé E, Dantzer F.
    Bull Cancer; 2015 Oct 24; 102(10):863-73. PubMed ID: 26384693
    [Abstract] [Full Text] [Related]

  • 10. Development of PARP inhibitors: an unfinished story.
    Patel A, Kaufmann SH.
    Oncology (Williston Park); 2010 Jan 24; 24(1):66, 68. PubMed ID: 20187324
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Cancer therapy by PARP inhibitors].
    Seimiya H.
    Nihon Rinsho; 2015 Aug 24; 73(8):1330-5. PubMed ID: 26281686
    [Abstract] [Full Text] [Related]

  • 14. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F, Harter P, Ewald-Riegler N, Papsdorf M, Kommoss S, du Bois A.
    Expert Rev Anticancer Ther; 2010 Jul 24; 10(7):1125-36. PubMed ID: 20645701
    [Abstract] [Full Text] [Related]

  • 15. Resurrected cancer drug faces regulators.
    Ledford H.
    Nature; 2014 Jun 26; 510(7506):454. PubMed ID: 24965630
    [No Abstract] [Full Text] [Related]

  • 16. PARP inhibition in BRCA-mutated breast and ovarian cancers.
    Chan SL, Mok T.
    Lancet; 2010 Jul 24; 376(9737):211-3. PubMed ID: 20656109
    [No Abstract] [Full Text] [Related]

  • 17. PARP inhibitors plough on.
    Mullard A.
    Nat Rev Drug Discov; 2017 Mar 30; 16(4):229. PubMed ID: 28356598
    [No Abstract] [Full Text] [Related]

  • 18. PARP inhibitors: what we know and what we have yet to know.
    Puhalla S.
    Oncology (Williston Park); 2010 Jan 30; 24(1):62, 65-6. PubMed ID: 20187323
    [No Abstract] [Full Text] [Related]

  • 19. Inducing synthetic lethality using PARP inhibitors.
    Boss DS, Beijnen JH, Schellens JH.
    Curr Clin Pharmacol; 2010 Aug 30; 5(3):192-5. PubMed ID: 20406170
    [Abstract] [Full Text] [Related]

  • 20. Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms.
    Maxmen A.
    J Natl Cancer Inst; 2010 Aug 04; 102(15):1110-1. PubMed ID: 20668266
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.